my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
04-07-2012: Medicyte and the Universities of Manchester and Pisa launch a European wide unique project with the aim to design a biomimetic bioartificial liver (Re-Liver). The company GABO:mi ensures professional project management.
The aim of Re-Liver is to reconstitute a standardized and reproducible bioartificial liver organoid (BLO) using healthy human liver as an architectural and biomaterial template. According to the EMA criteria, the BLO is a cell-based medicinal product, a highly innovative and complex medicine. In addition to the Advanced Therapy Medicinal Product (ATMP), new diagnostic tools and further products in cell-based applications will be developed and validated by the Re-Liver Consortium, made up of three industrial partners, all SMEs, focusing the commercialisation of market-leading products across Europe and further afield. The results of Re-Liver could be used for minimal invasive implantation to treat metabolic diseases, such as Haemophilia A, minimizing the transition from concept to clinic, and finally as an alternative for solid organ transplantation - giving new hope to over 10,000 people waiting for a liver transplant in the EU.
This research is receiving funding (4.2 Mio Euros) from the European Union Seventh Framework Programme (FP7/ 2007-2013) under grant agreement n° 304961.
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
Medicyte Coordinates EU-funded Collaboration on Biomimetic Bioartificial Liver
Medicyte and the Universities of Manchester and Pisa launch a European wide unique project with the aim to design a biomimetic bioartificial liver (Re-Liver). The company GABO:mi ensures professional project management.The aim of Re-Liver is to reconstitute a standardized and reproducible b ... more
Medicyte Awarded ISO 9001 Certification
Offering a new and unique technology to propagate primary human cells to virtually unlimited numbers, Medicyte has now gone a step further in its high quality policy. As announced, its quality management system was certified in December 2011 to meet the criteria of the globally recognized s ... more
Medicyte and PRIMACYT Receive Grant to Develop Human Liver Cells for Cell-based Therapies
Medicyte and PRIMACYT have received a 300k Euro grant from the BMBF to develop culturing methods of human hepatocytes for use in cell-based therapies.Cell-based therapies and the development of transplantable bioartificial livers to treat severe liver diseases still fail due to the limited ... more
What determines the stability of proteins?
With mathematical methods and computer simulations, Humboldt Fellow Richard Henchman (University of Manchester) is exploring the factors of protein stability – Research stay at the Heidelberg Institute for Theoretical Studies (HITS), supported by the Alexander von Humboldt foundation. Since ... more
Sweet news for stem cell's 'Holy Grail'
Scientists have used sugar-coated scaffolding to move a step closer to the routine use of stem cells in the clinic and unlock their huge potential to cure diseases from Alzheimer's to diabetes. The problem facing scientists is how to encourage stem cells to turn into the particular type of ... more
UK scientists have designed a high throughput method to determine the phenotypes of the different Escherichia coli strains that cause urinary tract infections. The method couples bacterial growth requirements to Fourier transform infrared spectroscopy. The majority of urinary tract infectio ... more
The University of Manchester is Britain's largest single-site university with a proud history of achievement and an ambitious agenda for the future. more
Medicyte Coordinates EU-funded Collaboration on Biomimetic Bioartificial Liver
Medicyte and the Universities of Manchester and Pisa launch a European wide unique project with the aim to design a biomimetic bioartificial liver (Re-Liver). The company GABO:mi ensures professional project management.The aim of Re-Liver is to reconstitute a standardized and reproducible b ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
